Principia Wealth Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$200K Buy
167
+19
+13% +$19.4K 0.1% 74
2026
Q1
$136K Buy
148
+104
+236% +$105K 0.08% 87
2025
Q4
$47.3K Buy
44
+5
+13% +$4.78K 0.03% 129
2025
Q3
$29.8K Buy
39
+5
+15% +$3.72K 0.02% 148
2025
Q2
$26.5K Buy
34
+9
+36% +$6.99K 0.02% 128
2025
Q1
$18.8K Buy
25
+6
+32% +$4.99K 0.02% 112
2024
Q4
$14.7K Buy
+19
New +$15.7K 0.01% 112

Other funds holding LLY

Principia Wealth Advisory's LLY Position: Q2 2026 in Review

Principia Wealth Advisory increased its Eli Lilly (LLY) stake by 13% in Q2 2026, buying an estimated $19.4K and bringing the position to 167 shares worth $200K. The position accounts for 0.1% of the portfolio, ranked #74.

Principia Wealth Advisory first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Principia Wealth Advisory held 167 shares of Eli Lilly worth $200K as of Q2 2026.
  • Principia Wealth Advisory bought 19 Eli Lilly shares in Q2 2026, an estimated $19.4K.
  • Eli Lilly made up 0.1% of Principia Wealth Advisory's portfolio in Q2 2026, its #74 holding.
  • Principia Wealth Advisory first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Principia Wealth Advisory's 13F filing for Q2 2026, filed 26 Aug 2026.